PMC:7212949 / 5322-5517 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T29","span":{"begin":184,"end":189},"obj":"Phenotype"}],"attributes":[{"id":"A29","pred":"hp_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/HP_0001945"}],"text":"• Abnormal CXR (59% on admission, 98% anytime)\n• 63% patients – first unifocal infiltrates at 4.5 ± 2.1 days\n• 37% patients - started as multifocal infiltrates at 5.8 ± 1.3 days after fever onset"}

{"project":"LitCovid-sentences","denotations":[{"id":"T56","span":{"begin":47,"end":108},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"• Abnormal CXR (59% on admission, 98% anytime)\n• 63% patients – first unifocal infiltrates at 4.5 ± 2.1 days\n• 37% patients - started as multifocal infiltrates at 5.8 ± 1.3 days after fever onset"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T479","span":{"begin":16,"end":21},"obj":"UBERON:0001443"},{"id":"T480","span":{"begin":59,"end":70},"obj":"GO:0015671"},{"id":"T481","span":{"begin":119,"end":126},"obj":"CHEBI:24996;CHEBI:24996"},{"id":"T482","span":{"begin":143,"end":147},"obj":"UBERON:0002084"},{"id":"T483","span":{"begin":149,"end":174},"obj":"UBERON:0002084"}],"text":"• Abnormal CXR (59% on admission, 98% anytime)\n• 63% patients – first unifocal infiltrates at 4.5 ± 2.1 days\n• 37% patients - started as multifocal infiltrates at 5.8 ± 1.3 days after fever onset"}